Nigeria Reports 144 New Coronavirus Cases 

Three instances were recorded in Kaduna State, one in Bauchi, and one each in Ekiti and Plateau states.

By Omotayo Olutekunbi

Between August 14 and August 15, there were 144 new cases each day, according to the Nigeria Centre for Disease Control (NCDC).

On Tuesday, August 16, 2022, the NCDC said on its official website that Lagos state reported 101 instances of the 144 new illnesses, while Abia verified 13 further cases.

The organization further stated that there were 10 new instances in Akwa-Ibom, while there were 9 in the Federal Capital Territory (FCT), 3 in Kano State, and the other cases came from other states.

Three instances were recorded in Kaduna State, one in Bauchi, and one each in Ekiti and Plateau states.

The NCDC also stated that there were no instances in Ogun, Ondo, Osun, Oyo, Rivers, or Sokoto.

According to the organization, the number of infections in the nation grew to 262,664 as a result of the most recent instances, while 3,147 people died as a result.

The NCDC website noticed the rise in Lagos with a wide disparity between it and other states in its breakdown of the most recent illnesses.

Lagos state confirmed 102,849 infections of the 262,664 total cases since the pandemic’s onset in February 2020, followed by the FCT and Rivers with 29,070 and 17,656, respectively.

In contrast to the 256,334 patients who have been treated and released around the country since the virus’s emergence more than two years ago, 3,917 people are now sick with it.

According to the News Agency of Nigeria (NAN), COVID-19 is now spreading rapidly over the world. Fortunately, the majority of them are only showing minor symptoms, in great part because of the high immunization rate.

The fundamental causes of certain people’s considerably more severe disease trajectories, however, are still not well understood.

The human DNA may contain the answer to why some people are more severely affected by COVID-19 than others. Researchers from the Berlin Institute of Health at Charité (BIH), in collaboration with peers from the UK and Canada, have identified genes and proteins that raise the chance of developing severe COVID-19.